Why Hoya’s MiYOSMART lenses quietly change everyday seeing

Hoya’s MiYOSMART spectacle lenses look like normal kids’ glasses, but behind the clear surface sits a myopia-control technology that targets one of the biggest eye-health issues of our time. What parents can expect in daily use - and where the limits lie.

Reviewed: ad hoc news Software & Services desk. Edited and checked on 2026-06-18, 10:45. Details in the imprint.

At first glance MiYOSMART lenses from Hoya look like any neat pair of children’s glasses resting on a school desk, but a closer look reveals a purposeful design aimed at slowing short-sightedness rather than just sharpening the view of the whiteboard.

What MiYOSMART is trying to solve

MiYOSMART is Hoya’s spectacle lens for children and teenagers that does not just correct myopia, but is designed to slow its progression over several years through a special optical pattern in the lens surface. Myopia in children is rising sharply worldwide, especially in East Asia, and can lead to serious eye issues later in life if it becomes high myopia.

Hoya developed MiYOSMART together with The Hong Kong Polytechnic University, basing the lens on a so-called Defocus Incorporated Multiple Segments (DIMS) technology. Instead of one continuous corrective power, the lens combines a central clear zone with hundreds of small segments that create myopic defocus, which research suggests tells the eye to stop elongating.

How the lens feels in daily use

On the nose, MiYOSMART feels like a standard lightweight plastic lens - no visible gadgets, no batteries, nothing that blinks. Children can run, sweat, and push the frame up with one finger without feeling a ridge or pattern because the tiny segments are blended smoothly into the surface.

Parents often worry whether such a technical lens will distort vision, but the core design aims to keep central vision clear while the surrounding segments work quietly in the background. Review reports from eye-care professionals describe that most kids adapt within days, much like they do to a new prescription.

The numbers behind myopia control

In a two-year clinical trial involving Chinese children aged 8 to 13, MiYOSMART lenses reportedly slowed myopia progression by an average of 60 percent compared with single-vision lenses. The same study found a similar reduction in axial eye growth, which is a key structural driver of higher myopia.

Hoya has since followed up with a six-year clinical study, presented as one of the longest-running datasets for a myopia-control spectacle lens. According to company information, the treatment effect remained stable over the extended period, and children who stopped using the lens did not show a sudden rebound effect.

What eye-care practices need to know

For opticians and optometrists, MiYOSMART is not a direct-to-consumer product, but part of a broader myopia-management program that includes eye exams, counseling on outdoor time, and screen habits. Hoya supplies training material and fitting guidelines so practices can explain the concept clearly to parents before they commit.

The lens is ordered with a prescription like a standard single-vision lens, but the lab production uses Hoya’s specific molds and quality checks to ensure the DIMS pattern is precise. Many practices position MiYOSMART alongside other myopia control options such as orthokeratology lenses or low-dose atropine, giving families a spectacle-based choice.

Fit, durability, and kid-proof details

In daily school life, durability matters more than whitepaper diagrams, and Hoya has added details targeting that reality. MiYOSMART is available with an impact-resistant polycarbonate called Eye Shield, which helps protect against ball hits in sports or rough playground collisions.

The lenses also come with full UV protection and can be combined with different frame styles so the child does not feel singled out with obvious “special” glasses. Surfaces can be coated with anti-reflection and scratch-resistant layers; however, parents still need to remind kids about cleaning with microfiber cloths rather than shirt sleeves.

Pricing and availability by region

MiYOSMART is positioned as a premium myopia-control solution and is typically more expensive than standard single-vision children’s lenses, though fees vary strongly between practices and countries. In key markets such as Hong Kong, Singapore, and parts of Europe, the lenses are available through selected partner opticians rather than large online retailers.

In Germany and other EU states, availability depends on local optician networks that have contracts with Hoya, and reimbursement by health insurers is limited or absent, which means families often bear most of the cost themselves. For many, the decision becomes a balance between long-term eye health concerns and current household budgets.

Where the concept meets its limits

MiYOSMART is not a cure for myopia, but an intervention to slow its progression, and results can differ between individual children. Proper wear time - typically full-time during waking hours - is crucial, so very young kids who tend to remove their glasses constantly may benefit less.

Eye-care professionals also stress that lifestyle still matters: even with advanced lenses, encouraging outdoor play and managing near work, especially smartphones and tablets, remains essential. Some children may initially notice mild visual artifacts in peripheral vision, but these often fade as the brain adapts.

Role in Hoya’s broader strategy and share

For Hoya, MiYOSMART fits neatly into a strategy of combining advanced optics with medical value, complementing its businesses in intraocular lenses and endoscopy systems. The product gives the company a foothold in the fast-growing global myopia-management market, where recurring lens replacements create steady revenue potential alongside traditional corrective eyewear.

Shares of Hoya Corp (JP3837800006) trade on the Tokyo Stock Exchange, where investors view healthcare-oriented products such as MiYOSMART as one pillar in the group’s mix of electronics, imaging, and life-care businesses.

Key facts on MiYOSMART at a glance

• Product: MiYOSMART myopia-control spectacle lens
• Manufacturer: Hoya Corp
• Category: Software/Service/Subscription-related medical optical solution
• Launch: First commercial launch in Asia in 2018, later rolled out to Europe and other regions
• RRP / Price: Typically positioned above standard single-vision kids’ lenses; exact price set by individual opticians per market
• Availability: Via selected eye-care professionals in markets including Hong Kong, Singapore, Japan, and several European countries
• Target group: Children and adolescents with progressing myopia, typically from around 6 to the mid-teens
• Highlight / USP: DIMS technology with hundreds of defocus segments aims to slow myopia progression while maintaining clear central vision

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.